Product name:Axitinib
CAS:319460-85-0
Molecular Formula:C22H18N4OS
Formula Weight:386.47g/mol
Description:It inhibits multiple targets, including VEGFR-1, VEGFR-2, VEGFR-3, platelet derived growth factor receptor (PDGFR), and cKIT (CD117). It has been shown to significantly inhibit growth of breast cancer in xenograft models and has been successful in trials with renal cell carcinoma (RCC) and several other tumor types.